These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35345272)

  • 1. Insights into Concomitant Atrial Fibrillation and Chronic Kidney Disease.
    Wang Y; Yang Y; He F
    Rev Cardiovasc Med; 2022 Mar; 23(3):105. PubMed ID: 35345272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial Fibrillation in Patients with Chronic Kidney Disease.
    Kotalczyk A; Ding WY; Wong CF; Rao A; Gupta D; Lip GYH
    Cardiol Clin; 2021 Aug; 39(3):435-446. PubMed ID: 34247756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey.
    Potpara TS; Lenarczyk R; Larsen TB; Deharo JC; Chen J; Dagres N;
    Europace; 2015 Dec; 17(12):1862-7. PubMed ID: 26733617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral anticoagulation and cardiovascular outcomes in patients with atrial fibrillation and chronic kidney disease in Asian Population, Data from the COOL-AF Thailand registry.
    Chantrarat T; Krittayaphong R
    Int J Cardiol; 2021 Jan; 323():90-99. PubMed ID: 32828960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management and 1-Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD - AF Registry.
    Goto S; Angchaisuksiri P; Bassand JP; Camm AJ; Dominguez H; Illingworth L; Gibbs H; Goldhaber SZ; Goto S; Jing ZC; Haas S; Kayani G; Koretsune Y; Lim TW; Oh S; Sawhney JPS; Turpie AGG; van Eickels M; Verheugt FWA; Kakkar AK;
    J Am Heart Assoc; 2019 Feb; 8(3):e010510. PubMed ID: 30717616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonvitamin K Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Renal Dysfunction.
    Mahmood M; Lip GYH
    Rev Esp Cardiol (Engl Ed); 2018 Oct; 71(10):847-855. PubMed ID: 29958809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
    Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
    J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke prevention in atrial fibrillation patients with chronic kidney disease.
    Hart RG; Eikelboom JW; Brimble KS; McMurtry MS; Ingram AJ
    Can J Cardiol; 2013 Jul; 29(7 Suppl):S71-8. PubMed ID: 23790601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intersection of cardiovascular disease and kidney disease: atrial fibrillation.
    Bansal N; Hsu CY; Go AS
    Curr Opin Nephrol Hypertens; 2014 May; 23(3):275-82. PubMed ID: 24709949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease.
    Kimachi M; Furukawa TA; Kimachi K; Goto Y; Fukuma S; Fukuhara S
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011373. PubMed ID: 29105079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of atrial fibrillation and chronic kidney disease.
    Ding WY; Gupta D; Wong CF; Lip GYH
    Cardiovasc Res; 2021 Mar; 117(4):1046-1059. PubMed ID: 32871005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of atrial fibrillation in patients with chronic kidney disease in clinical practice: a joint European Heart Rhythm Association (EHRA) and European Renal Association/European Dialysis and Transplantation Association (ERA/EDTA) physician-based survey.
    Potpara TS; Ferro C; Lip GYH; Dan GA; Lenarczyk R; Mallamaci F; Ortiz A; Sarafidis P; Ekart R; Dagres N
    Europace; 2020 Mar; 22(3):496-505. PubMed ID: 31965154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report.
    Bansal VK; Herzog CA; Sarnak MJ; Choi MJ; Mehta R; Jaar BG; Rocco MV; Kramer H
    Am J Kidney Dis; 2017 Dec; 70(6):859-868. PubMed ID: 28941763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation of renal function over time is associated with major bleeding in patients treated with direct oral anticoagulants for atrial fibrillation.
    Becattini C; Giustozzi M; Ranalli MG; Bogliari G; Cianella F; Verso M; Agnelli G; Vedovati MC
    J Thromb Haemost; 2018 May; 16(5):833-841. PubMed ID: 29460334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The connubium among diabetes, chronic kidney disease and atrial fibrillation.
    Magnocavallo M; Vetta G; Trivigno S; Mariani MV; DI Lullo L; Bellasi A; Della Rocca DG; Severino P; Piro A; Giunta G; Quaglione R; Lavalle C
    Minerva Cardiol Angiol; 2022 Jun; 70(3):393-402. PubMed ID: 35212508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic DOACs oral anticoagulation in patients with atrial fibrillation and chronic kidney disease: the nephrologist's perspective.
    Ravera M; Bussalino E; Fusaro M; Di Lullo L; Aucella F; Paoletti E
    J Nephrol; 2020 Jun; 33(3):483-495. PubMed ID: 32200488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical therapies for prevention of cardiovascular and renal events in patients with atrial fibrillation and diabetes mellitus.
    Fauchier L; Boriani G; de Groot JR; Kreutz R; Rossing P; Camm AJ
    Europace; 2021 Dec; 23(12):1873-1891. PubMed ID: 34411235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal function and outcomes after catheter ablation of patients with atrial fibrillation: The Guangzhou atrial fibrillation ablation registry.
    Deng H; Shantsila A; Xue Y; Bai Y; Guo P; Potpara TS; Zhan X; Fang X; Liao H; Wu S; Lip GYH
    Arch Cardiovasc Dis; 2019; 112(6-7):420-429. PubMed ID: 31133543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Stroke, Bleeding, and Death in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease.
    Arnson Y; Hoshen M; Berliner-Sendrey A; Reges O; Balicer R; Leibowitz M; Avgil Tsadok M; Haim M
    Cardiology; 2020; 145(3):178-186. PubMed ID: 31955174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Anticoagulant Agents in Patients With Atrial Fibrillation and CKD: A Systematic Review and Pairwise Network Meta-analysis.
    Su X; Yan B; Wang L; Lv J; Cheng H; Chen Y
    Am J Kidney Dis; 2021 Nov; 78(5):678-689.e1. PubMed ID: 33872690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.